Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Cash from Operations (2016)

Lixte Biotechnology Holdings' Cash from Operations history spans 7 years, with the latest figure at 469842.0 for Q4 2016.

  • For Q4 2016, Cash from Operations changed N/A year-over-year to 469842.0; the TTM value through Dec 2016 reached 1677447.0, changed N/A, while the annual FY2025 figure was 3070618.0, 2.97% up from the prior year.
  • Cash from Operations reached 469842.0 in Q4 2016 per LIXT's latest filing, up from 480132.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 248963.0 in Q1 2012 to a low of 7065729.0 in Q4 2013.
  • Average Cash from Operations over 5 years is 2582869.56, with a median of 515112.0 recorded in 2015.
  • Peak YoY movement for Cash from Operations: crashed 226.67% in 2012, then soared 39.5% in 2016.
  • A 5-year view of Cash from Operations shows it stood at 5885627.0 in 2012, then decreased by 20.05% to 7065729.0 in 2013, then surged by 94.91% to 359579.0 in 2014, then crashed by 41.54% to 508935.0 in 2015, then increased by 7.68% to 469842.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Cash from Operations are 469842.0 (Q4 2016), 480132.0 (Q3 2016), and 401588.0 (Q2 2016).